Bausch + Lomb, Inc.

Bausch + Lomb, Inc.

Bausch + Lomb, Inc.

Overview
Date Founded

1989

Headquarters

1400 North Goodman Street,Rochester, NY 14609

Type of Company

Private

Employees (Worldwide)

11K

Industries

Medical Products & Equipment
Hospitals & Patient Services
Wholesale: Medical Supplies & Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Biotechnology

Company Description

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Contact Data
Trying to get in touch with decision makers at Bausch + Lomb, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

AR Process Owner

Executive Vice President & Chief Operating Officer

Partner

General Manager

Board of Directors

Director at Talon Therapeutics, Inc.

Executive Officer at Vnomics Corp.

Paths to Bausch + Lomb, Inc.
Potential Connections via
Relationship Science
You
Bausch + Lomb, Inc.
Recent Transactions
Details Hidden

Bausch + Lomb, Inc., Bausch Health Cos., Inc. purchase Doctor's Allergy Formula LLC

Details Hidden

Bausch Health Cos., Inc. purchases Bausch + Lomb, Inc. from Warburg Pincus & Company US LLC

Details Hidden

Bausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase Technolas Perfect Vision GmbH from 20/10 Perfect Vision Operations GmbH

Transaction Advisors
Accountant

Advised onBausch + Lomb, Inc. purchases Storz Instrument Co. from Wyeth Corp.

Accountant

Advised onBausch + Lomb, Inc. purchases Sino Concept Technology Ltd. from Sino Biopharmaceutical Ltd.

Legal Advisor

Advised onBausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase ISTA Pharmaceuticals, Inc.

Legal Advisor

Advised onBausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase ISTA Pharmaceuticals, Inc.

Legal Advisor

Advised onBausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase ISTA Pharmaceuticals, Inc.

Legal Advisor

Advised onBausch + Lomb, Inc., Warburg Pincus & Company US LLC purchase ISTA Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

Partner at Connell Foley LLP

Legal Advisor

Senior Counsel at Cahill Gordon & Reindel LLP

Real Estate Agent

Managing Director at CBRE, Inc.

Clients

KeraLink International, Inc. operates as a non-governmental network of eye and tissue banks. It also provides ocular tissues used in transplant surgeries. The company was founded in 1962 and is headquartered in Baltimore, MD.

Key Stats and Financials As of 2020
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$2.35B
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
$64.5K
12/31/2011
Investments
Details Hidden

AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA.

Details Hidden

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client’s use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Investors
Details Hidden

Partners Group-PE is an active, long-term manager which follows an integrated approach to make direct, secondary and primary investments in private equity, leveraging its global network to source, analyze and execute a range of investments across asset classes globally.The firm makes direct private equity investments into the equity of selected operating companies, typically together with investee management and taking a board seat. It makes primary investments in newly established private equity partnerships where underlying portfolio companies are not known at the time of investment.It utilizes relative value assessment for different regions and financing stages to select the best private equity segments, seeking to identify and invest with high-quality partners from among its relationships with global private markets managers, advisory board committees and general and limited partners.Partners Group-PE makes secondary investments by acquiring single or portfolios of assets on the secondary market across all asset classes and offering investors liquidity or an exit possibility in a market which is highly liquidity-constrained. It is a value-based secondary investor which understands individual portfolio assets and business models at the fundamental level. It aims to create value by acquiring high quality assets with significant value potential and/or undervalued assets at itts point of inflection and searching for non-competitive acquisitions.

Details Hidden

TMT invests in life science and medical technology companies at all stages of development. The firm targets investments in pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. TMT participates in restructuring transactions including spin-outs, roll ups and recapitalizations.TMP typically invests $5 million to $40 million in one or more rounds of financing, with an average investment of more than $15 million over the life of an investment. Initial investments may be as small as $100,000. The firm prefers to lead the financing round in which they first participate.

Details Hidden

Warburg Pincus invests in companies located in the US primarily in North America, Europe and Asia.. The firm focuses on investments in the following sectors: financial services, healthcare, energy, consumer/manufacturing/industrials and technology, media and telecommunications (TMT). They participates in venture capital investments, growth equity investments, spin-outs, LBOs and special situation opportunities. They invest primarily in North America, Europe and Asia.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bausch + Lomb, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bausch + Lomb, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Bausch + Lomb, Inc..